We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+13.82%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$13B
AUM Growth
+$1.56B
(+14%)
Cap. Flow
+$261M
Cap. Flow
% of AUM
2.02%
Top 10 Holdings %
Top 10 Hldgs %
17.05%
Holding
1,179
New
174
Increased
377
Reduced
434
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$128M |
| 2 |
Electronic Arts
EA
|
+$79.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$75M |
| 4 |
Target
TGT
|
+$74.4M |
| 5 |
Amazon
AMZN
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Starbucks
SBUX
|
+$121M |
| 3 |
Micron Technology
MU
|
+$83M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$58.2M |
| 5 |
Kimberly-Clark
KMB
|
+$53.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Healthcare | 14.04% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Financials | 12.63% |
| 5 | Industrials | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Spyre Therapeutics
SYRE
$8.5B
| $1.5M | 0.01% |
7,577
+2,926
| +63% | +$561K |
|
|
EIGR
652
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.48M | 0.01% |
5,558
-1,230
| -18% | -$388K |
|
653
Metropolitan Bank Holding Corp
MCB
$1.15B
| $1.47M | 0.01% |
29,169
+572
| +2% | +$26.5K |
|
|
KYNB
654
Kyntra Bio
KYNB
$27.4M
| $1.46M | 0.01% |
1,679
-3,213
| -66% | -$3.42M |
|
|
VRS
655
DELISTED
Verso Corporation
VRS
| $1.45M | 0.01% |
99,503
-41,368
| -29% | -$544K |
|
|
HOLX
656
DELISTED
Hologic
HOLX
| $1.45M | 0.01% |
19,480
+1,060
| +6% | +$80.5K |
|
|
ADMS
657
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.44M | 0.01% |
300,246
+78,456
| +35% | +$410K |
|
658
Everspin Technologies
MRAM
$303M
| $1.44M | 0.01% |
239,536
+73,745
| +44% | +$433K |
|
659
Manhattan Associates
MANH
$12.1B
| $1.44M | 0.01% |
12,229
-2,495
| -17% | -$302K |
|
|
ABMD
660
DELISTED
Abiomed Inc
ABMD
| $1.43M | 0.01% |
4,497
-4,889
| -52% | -$1.56M |
|
661
Sprout Social
SPT
$530M
| $1.43M | 0.01% |
+24,752
| New | +$1.55M |
|
662
Commercial Vehicle Group
CVGI
$147M
| $1.42M | 0.01% |
147,518
+37,079
| +34% | +$347K |
|
663
Travelzoo
TZOO
$76.7M
| $1.42M | 0.01% |
84,440
-40,525
| -32% | -$530K |
|
|
HTB
664
HomeTrust Bancshares
HTB
$866M
| $1.41M | 0.01% |
58,062
-910
| -2% | -$20.6K |
|
665
AutoNation
AN
$7.7B
| $1.4M | 0.01% |
+15,065
| New | +$1.21M |
|
666
Monolithic Power Systems
MPWR
$61.4B
| $1.4M | 0.01% |
3,968
-539
| -12% | -$196K |
|
|
PVLA
667
Palvella Therapeutics
PVLA
$2.05B
| $1.39M | 0.01% |
6,760
+80
| +1% | +$17.5K |
|
668
STRATTEC Security
STRT
$376M
| $1.39M | 0.01% |
29,585
+22,624
| +325% | +$1.16M |
|
669
Golar LNG
GLNG
$4.82B
| $1.35M | 0.01% |
+132,091
| New | +$1.48M |
|
|
ILPT
670
Industrial Logistics Properties Trust
ILPT
$582M
| $1.34M | 0.01% |
+57,767
| New | +$1.3M |
|
|
CONN
671
DELISTED
Conn's Inc.
CONN
| $1.33M | 0.01% |
+68,525
| New | +$1.01M |
|
|
RVLP
672
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $1.33M | 0.01% |
+408,618
| New | +$1.68M |
|
673
Axcelis
ACLS
$3.44B
| $1.33M | 0.01% |
32,321
-130,336
| -80% | -$4.86M |
|
674
Five Below
FIVE
$11.6B
| $1.33M | 0.01% |
+6,962
| New | +$1.31M |
|
675
Universal Technical Institute
UTI
$2.26B
| $1.33M | 0.01% |
227,211
-52,989
| -19% | -$327K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2021 Portfolio in Review
As of Q1 2021, Jacobs Levy Equity Management held 1,179 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management's Q1 2021 filing shows 174 new, 377 increased, 434 reduced and 179 closed positions. Its largest new stake was Target: 397,775 shares worth $78.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q1 2021 buy was Target: 397,775 shares worth $78.8M.
- Jacobs Levy Equity Management added most to Costco in Q1 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- Jacobs Levy Equity Management fully exited Starbucks in Q1 2021, selling an estimated $121M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $13B portfolio in Q1 2021.
- Jacobs Levy Equity Management opened 174 new positions and closed 179 in Q1 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $13B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2021, filed 17 May 2021.